YR

Yamini Rapuru

Active Director Director DIN 09608500
DIN 09608500 First appointment May 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Yamini Rapuru

Data last updated:

Yamini Rapuru is a Director at Gravitas Biosciences Private Limited (since 2022) and Director at Innovative Clinical Research Private Limited (since 2022). The companies operate in Chemicals.

DIN 09608500
Primary Designation Director
Industry Chemicals
First Appointment 17 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gravitas Biosciences Private Limited U24100TG2022PTC162820
Director20 May 20222022Active
Director17 May 20222022Active

Board colleagues of Yamini Rapuru

Directorship timeline

Open interactive timeline →
Innovative Clinical Research Private Limited
Gravitas Biosciences Private Limited
Premium access

Shareholding and investment profile for Yamini Rapuru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yamini Rapuru

Yamini Rapuru currently holds 2 directorships: Gravitas Biosciences Private Limited (Director, since 20 May 2022); Innovative Clinical Research Private Limited (Director, since 17 May 2022).

Yamini Rapuru was first appointed on 17 May 2022 as Director at Innovative Clinical Research Private Limited.

The current boards of Yamini Rapuru's companies include Jyothi Dudala (Gravitas Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available